Cytokine Network: New Targeted Therapy for Pancreatic Cancer

Author(s): Yoichi Matsuo, Hiromitsu Takeyama, Sushovan Guha

Journal Name: Current Pharmaceutical Design

Volume 18 , Issue 17 , 2012

Become EABM
Become Reviewer
Call for Editor


Increasing evidence has shown that cytokines have a role in tumor biology. The role of chemokines in tumor biology is important because these peptides may influence tumor growth, invasion, angiogenesis, and metastasis. In this review, we demonstrated the role of cytokines (Interleukin-1α, hepatocyte growth factor, Interleukin-8, stromal cell-derived factor-1 and CXC-chemokines/CXCR2 biological axis) in pancreatic cancer angiogenesis, especially from the standpoint of the interaction between tumor and its microenvironments. The cytokines are intimately related with cancer angiogenesis. Blocking these cytokines could attenuate pancreatic cancer associated angiogenesis and further considered as a novel anti-angiogenic target in pancreatic cancer.

Keywords: Pancreatic cancer, cytokine, angiogenesis, targeted therapy

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [2416 - 2419]
Pages: 4
DOI: 10.2174/13816128112092416
Price: $65

Article Metrics

PDF: 38